Commission action will be decisive for innovation
This article was originally published in Clinica
The European Commission’s exploratory process on the future of the medical devices sector has begun and meetings are already underway. What subjects are likely to emerge as those chosen for further reflection? Commission expert Guilia del Brenna discusses the possibilities in the context of developments in the pharmaceutical sector
You may also be interested in...
While the UK is moving forward quickly to provide COVID-19 antibody self-testing, the Belgian government considers the tests not sufficiently accurate to be used in the pandemic.
Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.
The UK is taking measures to increase its ventilator stock from 8,000 to some 30,000, but it will take time to make them available. Many are asking whether the government really rejected EU help, which could have brought relief sooner, because of Brexit.